2012 annual financial data
BriaCell Therapeutics 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -559,615 USD and net income was -998,987 USD.
Operating cash flow was -382,742 USD.
Get free BriaCell Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -559,615 USD
- Net income
- -998,987 USD
- Operating cash flow
- -382,742 USD